Ranibizumab in South Korean and Taiwanese patients with age-related macular degeneration: Primary outcome of the EXTEND III study

Fenq Lih Lee; Oh Woong Kwon; Hum Chung; Chi Chun Lai; Shwu Jiuan Sheu; Young Hee Yoon

doi:10.1111/j.1755-3768.2011.02262.x

Ranibizumab in South Korean and Taiwanese patients with age-related macular degeneration: Primary outcome of the EXTEND III study

Fenq Lih Lee
, Oh Woong Kwon^*
, Hum Chung
, Chi Chun Lai
, Shwu Jiuan Sheu
, Young Hee Yoon

^*Corresponding author for this work

Research output: Contribution to journal › Journal Letter › peer-review

5 Scopus citations

Original language	English
Pages (from-to)	e406-e407
Journal	Acta Ophthalmologica
Volume	90
Issue number	5
DOIs	https://doi.org/10.1111/j.1755-3768.2011.02262.x
State	Published - 08 2012
Externally published	Yes

Access to Document

10.1111/j.1755-3768.2011.02262.x

Cite this

@article{82c3c8f938214857aae47360df6d3f4c,

title = "Ranibizumab in South Korean and Taiwanese patients with age-related macular degeneration: Primary outcome of the EXTEND III study",

author = "Lee, \{Fenq Lih\} and Kwon, \{Oh Woong\} and Hum Chung and Lai, \{Chi Chun\} and Sheu, \{Shwu Jiuan\} and Yoon, \{Young Hee\}",

year = "2012",

month = aug,

doi = "10.1111/j.1755-3768.2011.02262.x",

language = "英语",

volume = "90",

pages = "e406--e407",

journal = "Acta Ophthalmologica",

issn = "1755-375X",

publisher = "John Wiley and Sons Inc",

number = "5",

}

TY - JOUR

T1 - Ranibizumab in South Korean and Taiwanese patients with age-related macular degeneration

T2 - Primary outcome of the EXTEND III study

AU - Lee, Fenq Lih

AU - Kwon, Oh Woong

AU - Chung, Hum

AU - Lai, Chi Chun

AU - Sheu, Shwu Jiuan

AU - Yoon, Young Hee

PY - 2012/8

Y1 - 2012/8

UR - https://www.scopus.com/pages/publications/84864403617

U2 - 10.1111/j.1755-3768.2011.02262.x

DO - 10.1111/j.1755-3768.2011.02262.x

M3 - 快报

C2 - 22280368

AN - SCOPUS:84864403617

SN - 1755-375X

VL - 90

SP - e406-e407

JO - Acta Ophthalmologica

JF - Acta Ophthalmologica

IS - 5

ER -

Ranibizumab in South Korean and Taiwanese patients with age-related macular degeneration: Primary outcome of the EXTEND III study

Access to Document

Other files and links

Cite this